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The present work focused on Phytochemical screening, characterization, anticancer activity and antibiological activity of 
ethyl acetate extract of Melochia corchorifolia leaves followed by molecular docking studies have been carried out. The 
plant leaves have been collected, weighed, and extracted with the soxhlet apparatus by using ethyl acetate solvent and then 
extracted are subjected to phytochemical screening.  Antibiological activity of plant leaves ethyl acetate extract has been 
tested against six bacterial and two fungal strains using agar well diffusion methodology. The characterization of 
phytoconstituents compounds has been carried out using various spectroscopy method such as GC-MS 
(Gas chromatography Mass spectroscopy), UV-visible and Fourier-transform infrared. Auto dock tool (4.2.0) is used for 
molecular docking studies. The phytochemical analysis of Melochia corchorifolia ethyl acetate leaves, reveals the existence 
of carbohydrates, glycosides, triterpenes flavonoids and alkaloids. Antimicrobial activity is effective against gram-positive 
bacterial strains namely Staphylococcus aureus (17 mm), Bacillus subtilis (16 mm), the gram-negative bacterial strains 
namely Salmonella typhi (15 mm) and E. coli (14 mm). Moreover, the extract is also found to be effective 
against Aspergillus Niger (18 mm) fungal species. The GC-MS and FT-IR analysis show bioactive compounds and their 
functional groups. UV-VIS analysis results reveal that the presence of phytoconstituents derivatives in the range between 
206-350 nm. The cytotoxicity activity for the MCF-7 cell line shows that the drug efficacy IC50 value is 148.836
(μg/mL). Further, the predicted bioactive compounds are docked with the cancer estrogen protein receptor (PDB ID: 3s7s)
with ligand martidin-15 one shows the highest binding affinity. The study reveals the potential of Melochia
corchorifolia leaves ethyl acetate extract showed antibiological and anticancer activity.
Keywords: Anticancer activity, Antimicrobial activit, FTIR, GC-MS, Human breast cancer estrogen protein, Molecular 
Docking, Melochia corchorifolia, UV-VIS 
The human system is mainly composed of numerous 
tiny cells. Normal cells in human system grow and 
divide in the body for a period of time and then stop 
dividing and growing. Cellular reproduction plays an 
extensive role in immune system once the process 
goes out of govern cancer cell occurs. Therefore, the 
abnormal division and growth noticed in cancer cells 
which are caused by damage in the genetic material1.
Breast cancer is one of the utmost serious 
complications of oncology. The huge amount of threat 
factors has been identified which advance chance of 
cancer, such as exposure to radiation, obesity, 
smoking chemical mutagens, environmental 
pollutants, alcohol consumption and lack of physical 
exercise. A large number of anticancer drugs are 
currently available in progress; unfortunately, the side 
effects of the synthetic drugs are an extensive 
drawback in clinical study. The entire world is 
facing problem in the enlargement of drugs for 
various cancer remains extreme clinical challenges2-4. 
On the other hand, Plants are found to be a feasible 
source in the cancer treatment.  India has identified 
more than 3000 medicinal plants. Natural products are 
playing major role treatment of various diseases and 
playing a significant role in drug development5-7. The 
parts of the plants have been used over the last several 
decades to cure different diseases. The exploration 
for infectious agents has engaged many research 
organizations in the territory of ethno pharmacology8, 9. 
Characterization of the phytochemical compounds 
from the medicinal plants will add information on the 
various functional groups which are mainly 
responsible for the therapeutic properties. The drugs 
from medicinal plants have shown a good antitumor 
activity against breast cancer, such as Paclitaxel 
and Docetaxel (Taxus brevifolia), Camptothecin 




(Camptotheca acuminata) and Vinblastine 
(Catharanthus roseus). Drugs are involved in 
inhibiting the cell cycle mechanism and thereby 
inhibiting the DNA topoisomerase and microtubule 
assembly10-13. The main purpose of molecular docking 
is to obtain the preliminary information of any 
bioactive compound's affinity before the in-vitro 
experiment. In this analysis, three parameters such as 
H-bonding energy, binding energy, and inhibition 
constant were evaluated a protein receptor ligand for 
binding affinity14,15. The estrogen receptor used 
therapeutic importance as a target to prevent 
osteoporosis and breast cancer16.  
Melochia corchorifolia has been conventionally 
used for different medicinal purposes. In India, the 
plants of Melochia corchorifolia are used to treat 
several diseases like to reduce abdominal swelling, 
headache, ulcer, chest pain, and cancer 
treatment. Melochia corchorifolia will grow tall up to 
1.3-2.0 m with stellate hairs. The leaves are ovate in 
shape and blade of narrow leaves measures up to  
7.5 cm × 5.5 cm and veins measured 5 cm to 7 cm 
long. The petioles are typically 5 cm long and have 
linear stipules17-19. In this study, scrutinized the 
presence of phyto constituents, analyzed its anti-
biological activity and evaluated bioactive phyto 
constituents from Melochia corchorifolia leaves ethyl 
acetate extract and In-silico studies on human breast 





Ethyl acetate extract 
Melochia corchorifolia leaves collected from the 
various surroundings Vandalur, India. The freshly 
collected leaves washed and air dried for 15 days in 
the shade to remove chlorophyll content. Using a 
mechanical blender, the leaves of Melochia 
corchorifolia are finely grounded into a powder.   
The 100 g of air-dried ground leaf material was 
extracted with ethyl acetate in the ratio of 1:10 (w/v) 
using soxhlet apparatus for 72 hrs at 50-60C. The 
ethyl acetate extract then filtered by using Whatman 
filter paper No: 1 separate container. The above 
processes were repeated for three times. The collected 
ethyl acetate extract concentrated about 40C (rotary 
evaporator). Ethyl acetate was then added to increase 
the extraction volume to 100 mL. The concentrated 
extract of Melochia corchorifolia leaves were weighed 
lyophilized and kept at 4C for further studies20.  
Qualitative analysis of phytochemical screening 
The ethyl acetate extract of Melochia corchorifolia 
were subjected to preliminary phytochemical 
screening using standard methods. The sample  
extract was initially screened for different types of 
phyto constituents such as phenolic, terpenoids, 
alkaloids, and steroids etc. using standard 
reagents21,22.  
 
Antibacterial activity of Melochia corchorifolia 
The Ethyl acetate leaf extract have been  
screened against various microorganisms responsible 
for the infections23. The bacterial strains were 
obtained by the process of serial dilution and spread 
over an agar plate. For bacterial growth, the plates 
were incubated for 3-4 days at 37C. Species 
identifications were performed using standard 
methods. Antibacterial activity of Melochia 
corchorifolia ethyl acetate was evaluated by using 
both gram positive and negative bacteria including 
Staphylococcus aureus, Bacillus subtilis, 
Staphylococcus epidermis, strains Proteus vulgaris, 
Salmonella typhi, and Escherichia coli using agar 
well diffusion assay method. Nutrient agar plates 
were swabbed with 8 h old culture of each bacterium. 
Well performed in respective petri plates by sterile 
cork borer (10mm diameter, 2 cm apart). 
Approximately 100 μL of ethyl acetate extract added 
into wells using a sterile syringe kept room 
temperature for 2 h. The control experiments were 
carried out without using a plant leaves extract. The 
positive control ampicillin 100 μg/mL then incubated 
plates at 37C about 24 h bacterial growth. A zone of 
inhibition was observed after 24 h and the activity 
index was also calculated and above process was 
carried out thrice24-26. 
 
Analysis of antifungal activity 
The antifungal activity of plant leaves extract 
screened for agar well diffusion method27. Serial 
dilution method was used to isolate the fungi  
from soil samples. Pure fungal cultures were  
swabbed on the agar plates using sterilized cotton 
buds. Wells are made on the agar plates. Ethyl  
acetate extract of Melochia corchorifolia were tested 
against Aspergillus Niger and Candida albicans 
concentration 100 µg/mL. The Fluconazole as 
positive control and plates are incubated at 37C for 
48 h and precise and index activity zone of inhibition 
was calculated28-30.  





FT-IR spectral investigation of the ethyl acetate 
leaves extract sample accomplished using FT-IR 
Shimadzu IR Prestige-21 (FT-IR-84005). FT-IR 
spectrum provides the compositional and functional 
information of Melochia corchorifolia extract. The 
analysis was performed in range of wave number  
500-3500 cm-1 at room temperature by using the  
KBr pellet31,32.  
 
GC-MS 
A Clarus 500 Perkin-Elmer gas chromatography 
fitted with an Elite-5 capillary column (5 percent 
phenyl 95 percent dimethyl polysiloxane) (30 nm × 
0.25 mm ID × 0.25 μm df) with EI mode is used to 
test and run the GC-MS33,34.  
 
UV-VIS spectrum analysis  
The Melochia corchorifolia ethyl acetate extract 
was centrifuged at 4000 rpm for 15mins, followed by 
filtering using Whatmann filter paper No: 1. further 
dilution process was carried out in the ratio of 1:10 
with ethyl acetate. The extract was analyzed using 
Perkin Elmer Spectrophotometer at a wavelength 
ranging from 200 to 800 mm, and the characteristic 
peaks were recorded35,36.  
 
Protein and ligand preparation 
The three-dimensional complex structure of the 
protein Human Breast cancer estrogen receptor (PDB 
ID 3s7s) was retrieved from the protein databank37. 
The estrogen protein receptor was converted into 
native structure by deleting all the water and 
heteroatom molecules using the Auto dock 4.2.0 
software. The 2D structures obtained from GC-MS 
were changed to 3D clusters by using Open  
Babel tool38. 
 
Molecular docking analysis on protein Human Breast cancer 
estrogen receptor and potent ligand 
The computational docking analysis was performed 
by using software Auto Dock 4.2.0. Based on the 
literature review the automated process was 
performed to locate the appropriate active site and 
binding conformations of estrogen receptor protein by 
using Autodock 4.2.0 docking tool39. The cluster 
analysis was calculated on the docked results. The 
binding energy of each cluster is calculated for all 
different docked pose of conformations with  
the ligand Sophoridine, Martridin-15-one and  
Phytol acetate. 
Swiss ADME 
Swiss ADME web tool is used to computing the 
physicochemical properties of drug-likeness and 
pharmacokinetic nature of small ligand. This method 
used to support drug-designing study40.  
 
PASS prediction 
The (BAS) biological activity spectrum was 
calculated by using the PASS prediction method. The 
outcomes of the ligand exhibit pharmacological, 




The MCF-7 cells subculture was subsequently 
trypsinized in DMEM after that medium of culture 
eliminated. The flask with disaggregated cells is 
added with 25 mL of DMEM and 10% FCS42.  
 
Seeding of cells 
About 1 mL of a homogenized suspension of a cell 
has been applied to about 25 well culture plates along 
with different concentrations of the test ethyl acetate 
plant extract sample from 0 to 200μg/mL and  
37°C incubated at 5% CO2 humidified. The cells are 
observed (inverted tissue culture microscope) after 48 
h incubation, with a cytotoxicity assay of 80% 
confluence of cells43.  
 
Cytotoxicity assay 
Assay test performed (3‐ (4, 5‐dimethyl 
thiazol‐2yl) ‐2, 5‐diphenyl tetrazolium bromide 
(MTT). The wells added with MTT after 48 hrs 
incubation left at room temperature for 3 h then wells 
removed the content using the pipette and added  
100 μl SDS in DMSO to dissolve formazan crystals 
absorbance was reader at 570 nm Read Well Touch 
microplate reader44. 
 
Results and Discussion 
 
Phytochemical analysis 
 Phytochemical scrutiny ethyl acetate extract 
Melochia corchorifolia leaves are show in (Table 1). 
The analysis report has exposed the occurrence of 
bioactive secondary metabolites compounds 




The antimicrobial activity Melochia corchorifolia 
ethyl acetate leaves extract evaluated against \ 
Staphylococcus epidermis, Staphylococcus aureus, 




proteus vulgaris, Bacillus subtilis, Salmonella typhi, 
and Escherichia coli strains. The Melochia 
corchorifolia was found to be active against with a 
Staphylococcus aureus of 100 µg/mL (Table 2). 
Antifungal activity was evaluated for ethyl acetate 
extract against Aspergillus Niger and Candida 
albicans. The maximum zone of inhibition showed 
Aspergillus Niger ethyl acetate extract of the 
Melochia corchorifolia leaves. Similarly, Aerva 
lanata solvent organic extracts have shown a 
significant role in phytochemical and antimicrobial 
properties studied46 (Table 3). 
 
FT-IR analysis 
The FT-IR showed various peaks -NH stretching 
(3412 cm-1), sp3 hybridization -CH group (2929), C=C 
group (1634), C-C combination of stretch & bends 
group (1391 cm-1) and C-O group (1050 cm-1). Similar 
research was performed in the FT-IR spectral analysis 
study of Ampelocissus latifolia extract and stated that the 
occurrence of specific functional groups such as 
secondary amine, alkanes, and carbonyl compound45. 
The spectral analysis peak showed identification 
different functional groups and chemical bonds stretches 
value. (Table 4 and Fig. 1). 
 
GC-MS spectral analysis 
The GC-MS is most specific process to detect 
numerous secondary metabolites existing in the plant 
extracts. The ethyl acetate plant extract evaluated by 
GC-MS to detect various compounds with Mass 
Spectral library NIST 17 and Wiley 8 and compounds 
are identified. The chromatograph showed five peaks 
with five individual compounds shown in (Table 5 
and Fig. 2). The plant extract which contain higher 
level of major constituents is Phytol, acetate  
(30.43 Per cent), followed by Matridin-15-one (22.73 
Per cent), l-(+)-Ascorbic acid 2, 6-dihexadecanoate  
(22.10 Per cent), 2,6,10-Trimethyl,14-ethylene-14-
pentadecane (17.04 Per cent) and low level area is 
Sophoridine (7.70 Per cent). .  
 
UV-VIS spectrum analysis 
The spectrum analyses detect compounds contain 
σ-bonds, π-bonds (lone pair of electrons) aromatic 
 
Table 1 — Phytochemical screening of ethyl acetate extract of 
aerial parts of Melochia corchorifolia 
S.No Phyto constituents Test Result 
1 Alkaloids  Hager’s reagent & 
Wagner’s test 
+ 
2 Amino acid Ninhydrin test - 
3 Tannins  Ferric Chloride test - 
4 Triterpenes Terpenoids test + 
5 Carbohydrates  Molisch’s  + 
6 Glycosides  Borntrager’s  + 
7 Flavonoids Lead acetate  + 
8 Proteins  Millon’s  - 
9 Saponin Froth forming - 
 
Table 2 — Zone of inhibition ethyl acetate extract against 
microorganism 









Staphylococcus aureus 17 12 ̶̶ 
Bacillus subtilis 16 13 ̶ 
Staphylococcus 
epidermis 
13 14 ̶ 
Escherichia coli 14 10 ̶ 
Salmonella typhi 15 11 ̶ 
Proteus vulgaris 12 13 _ 
 













Aspergillus Niger 18 13 _ 
Candida albicans 12 11 _ 
 
 
Table 4 — FTIR spectrum and functional group obtained from the 
ethyl acetate extract 
S. No Extract Peak values 
cm-1 
  Functional groups 
1  
Ethyl acetate extract 
of Melochia 
corchorifolia 
3412 -N-H stretching  
(secondary amine) 
2 2929 -C-H stretching 
3 1634 -C=C group 
4 1391 -C-C (Combination of 
stretching and bending) 
5 1050 -C-O group 
 
 
Fig. 1 — FT-IR spectrum of Melochia corchorifolia leaves extract 
in ethyl acetate 




ring and chromophores. UV-VIS spectrum of  
leaf extract recorded at a wavelength between 200  
to 800 nm, because of sharpness peak at 206 nm with 
a proper baseline. The results showed other peaks 
326, 273 and 260 nm with spectral absorption 0.02, 
0.027, 0.186 and 0.024. UV-VIS spectroscopic  
(206-350 nm) result reveals that the existing of 
flavonoids and phenolic compound derivatives  
(Table 6). 
 
Molecular Docking analysis 
The present analysis reveals that ligand 
Matridin-15-one showed binding affinity of -7.75 
kcal/mol and high inhibition constant value, which 
indicates better affinity when compared to Phytol 
acetate. Hence, Matridin-15-one is the potential 
lead molecule for the inhibition of human cancer 
estrogen protein amino acid residues Arg86, Tyr52, 
Gly49, Pro50, Pro48, Gly51, and Arg343. They are 
the most significant amino acid residues for 
potential drug targets as carbon-hydrogen bond, 
conventional hydrogen bond, and Vander Waals 
 
 
Fig. 2 — Structure of active compounds identified by
GC-MS -ethyl acetate extract of Melochia corchorifolia
 leaves 
Table 6 — The Peak values of UV-VIS Spectrum of ethyl acetate 
extract of Melochia corchorifolia 
S.No. Wavelength (nm) Absorbance 
1 326 0.020 
2 273 0.027 
3 206 0.186 
4 260 0.024 
 
Table 7 — The binding affinity of ligand with estrogen breast 
cancer receptor protein 
Protein Pdb  
ID 




3s7s Matridin-15-one -7.75 328.65 
 Sophoridine -6.43 300.75 
 Phytol acetate -1.47 120.08 
Table 5 — Bioactivity phytocomponents detected- Melochia corchorifolia leaves 
S.no Retention 
time 






Compound name Nature of the 
compound 
Biological activity & Ref 




2 39.196 130118  22.10 C38H68O8 652.9 l-(+)-Ascorbic acid 2,6-
dihexadecanoate 
Fatty acid Ester  Antidiabetic, Antibacterial, 
Antibronchitic, Anticancer48 
3 43.735 179154  30.43 C22H42O2 338.6 Phytol, acetate Diterpene Antimicrobial, Anti- 
inflammatory, diuretic, 
Anticancer 49 
4 48.773 133858  22.73 C15H24N2O  248.36 Matridin-15-one Alkaloid Anti-inflammation,  
Anti-fibrotic  
Anticancer 50 









interaction. Theoretically, sophoridine also showed 
moderate binding affinity value of -6.43 (Table 7 
and Figure 3, 4 and 5). 
 
ADME toxicity testing 
The ADME/TOX analysis of the ligand Martidin-
15-one shows drug-likeness, obeys Lipinski rule five, 
no violation and high score value of bioavailability 
(Table 8). 
 
PASS prediction activity 
The PASS prediction analysis of ligand 
Martidin-15-one shows higher Pa value 
(Probability active value) for an anticancer 





The cytotoxicity effect against suspension adherent 
cell line MCF-7 is showed (Table 10 & Figure 6 & 7). 
The compound showed a good anticancer reactivity 
against MCF-7 cell line. There was dose dependant 
manner activity was observed. MCF-7 cell lines 
showed low level of cell viability (55.38%) registered 
in 400 µg/ml at 48 h, where as 48 h MCF-7 cell line 
showed low level of cell viability registered (85.46%) 
in 3.125 µg/mL. The IC50 value ethyl acetate extract 
of Melochia corchorifolia leaves calculated at  
148.36 µg/mL cell viability against MCF-7 cell  
lines. Similarly, ethyl acetate extract of Nepenthes 
plant reported that a better cell viability against  
MCF-7 cell line52.  
 
Fig. 4 — Binding interaction of Sophoridine in 3s7s Receptor   
Fig. 3 — Binding interactions of Matridin-15-one in 3s7s
Receptor 




Table 9 — Activity prediction for Martidin-15-one- Possible 
activities at Pa > 30 % 
Pa Pi Activity 
   
0.898 0.001 Antineoplastic alkaloid, Anticancer 
0.841 0.011 Nootropic 
0.836 0.006 Nicotinic alpha2beta2 receptor 
antagonist 
0.765 0.015 TP53 expression enhancer 
0.743 0.003 Fibrosis treatment 
0.740 0.003 CYP2D2 inhibitor 
0.726 0.005 Cognition disorders treatment 
0.729 0.008 Analgesic 
0.723 0.005 Analgesic, non-opioid 
0.717 0.004 Polarisation stimulant 
0.734 0.025 Nicotinic alpha6beta3beta4alpha5 
receptor antagonist 
0.709 0.007 Cardiovascular analeptic 
0.707 0.006 Antipsychotic, Antivenom 
0.702 0.004 Cholinergic 
 
Table 10 — In vitro cytotoxicity effect of ethyl acetate Melochia 
corchorifolia leaves extract against MCF-7 cell lines 













Fig. 5 — Binding interactions of Phytol acetate in 3s7s Receptor 
 
 
Fig. 6 — Anticancer activities of ethyl acetate Melochia
corchorifolia leaves extract  
Table 8 — ADME property of Martidin-15-one drug 
Molecule Canonical 
SMILES 














C15H24N2O 248.36 18 2 -6.69 0 0.55  
 
 
Fig. 7 — Graphical representation- Anticancer activity of ethyl 
acetate Melochia corchorifolia leaves extract  





Based on the present study, an antibiological 
analysis of Melochia corchorifolia ethyl acetate 
leaves extract have been identified which inhibits the 
growth of selected Gram-negative and Gram-positive 
bacterial and fungal species. The phytochemical result 
relies on the occurrence of various phytocomponents. 
UV-VIS, FT-IR, and GC-MS results reveal that active 
functional groups and bioactive compounds present in 
the leaves extract. Furthermore, it showed a 
significant inhibitory effect on MCF-7 cell line 
growth and proliferation. The molecular docking 
result indicated that the ligand compound Matridin-
15-one is having better binding affinity and inhibition 
constant for both aspects. The molecular docking 
investigation explained that the compound present in 
the leaves extract highly binding affinity with protein 
human breast cancer (estrogen receptor) and it might 
use to reduce lifetime exposure to estrogen. The 
consequences of various experiments, which were 
conducted in the present investigation, afford 
promising principles regarding the potential uses 
of Melochia corchorifolia for the estrogen protein 
receptor. Further, the ADME/TOX result reveals that 
the Martidin-15-one ligand shows a potent inhibitor 
for the targeted protein. PASS prediction results 
reveal that Martidin-15-one is a potential inhibitor for 
anticancer activity value. Future research requires a 
detailed investigation of active chemical constituents 
like isolation, characterization, and biological 
activities. This study boosts the efficacy of the 
bioactive compounds for destiny drug discovery 
through leading advanced techniques. 
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